TY-1210

N/A

Report date: 2024/10/14 16:11:40

NME

Base Information

Drug NameTY-1210

Drug Alias NameTY-1210

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCyclin-dependent kinase 2 inhibitors

TargetsCyclin-dependent kinase 2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesTYK Medicines Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A